Basit öğe kaydını göster

CSF levels of HoxB3 and YKL-40 may predict conversion from clinically isolated syndrome to relapsing remitting multiple sclerosis

dc.contributor.authorKürtüncü, Murat
dc.contributor.authorTürkoğlu, Recai
dc.contributor.authorGündüz, Tuncay
dc.contributor.authorYılmaz, Vuslat
dc.contributor.authorTüzün, Erdem
dc.contributor.authorTamam, Yusuf
dc.contributor.authorGüneş, Betül
dc.contributor.authorAkbayır, Ece
dc.contributor.authorKızılay, Tuğçe
dc.contributor.authorKaraaslan, Zerrin
dc.contributor.authorKoral, Gizem
dc.contributor.authorDüzel, Berna
dc.contributor.authorKüçükali, Cem İsmail
dc.date.accessioned2021-03-02T16:10:11Z
dc.date.available2021-03-02T16:10:11Z
dc.date.issued2020
dc.identifier.citationTamam Y., Güneş B., Akbayır E., Kızılay T., Karaaslan Z., Koral G., Düzel B., Küçükali C. İ. , Gündüz T., Kürtüncü M., et al., "CSF levels of HoxB3 and YKL-40 may predict conversion from clinically isolated syndrome to relapsing remitting multiple sclerosis", MULTIPLE SCLEROSIS AND RELATED DISORDERS, cilt.48, no.1, ss.102697, 2020
dc.identifier.issn2211-0348
dc.identifier.othervv_1032021
dc.identifier.otherav_fa04d7f8-0fbc-40ea-b6a3-adb6b7b0d91f
dc.identifier.urihttp://hdl.handle.net/20.500.12627/2394
dc.identifier.urihttps://doi.org/10.1016/j.msard.2020.102697
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S2211034820307719?via%3Dihub
dc.language.isoeng
dc.subjectKlinik Tıp (MED)
dc.subjectSağlık Bilimleri
dc.titleCSF levels of HoxB3 and YKL-40 may predict conversion from clinically isolated syndrome to relapsing remitting multiple sclerosis
dc.typeMakale
dc.relation.journalMULTIPLE SCLEROSIS AND RELATED DISORDERS
dc.contributor.department, ,
dc.identifier.volume48
dc.identifier.issue1
dc.identifier.startpage102697
dc.identifier.endpage102697
dc.contributor.firstauthorID2482494


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster